10-year battle for broad access ends for Keytruda
By Megan Brodie 1 month ago | In Products, Reimbursement- 1 month ago
31 August 2026 Hundreds more Australians with immunosensitive metastatic cancers will have publicly-funded access to…
This is subscriber-only content. Please login to continue reading.